Drug Shortage Report for PENICILLIN G SODIUM FOR INJECTION, USP

Last updated on 2018-03-07 History
Report ID 15623
Drug Identification Number 02220261
Brand name PENICILLIN G SODIUM FOR INJECTION, USP
Common or Proper name PENICILLIN G SODIUM
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) PENICILLIN G
Strength(s) 1000000UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 1 million unit SD vial
ATC code J01CE
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-07-12
Estimated end date
Actual end date 2018-03-06
Shortage status Resolved
Updated date 2018-03-07
Company comments The product is available to all customers through all distribution channels without any volume restrictions
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2018-03-07 English Compare
v6 2018-03-06 French Compare
v5 2018-03-06 English Compare
v4 2017-07-13 English Compare
v3 2017-07-12 French Compare
v2 2017-07-12 English Compare
v1 2017-07-12 English Compare

Showing 1 to 7 of 7